Makarand Madine, Raj Nandan Chennuri, Reshmanth Prathipati, Vedant Shah, Michael Maroules. "Real-world eligibility for perioperative pembrolizumab in resectable locally advanced head and neck squamous cell carcinoma: A SEER-based analysis following KEYNOTE-689.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e18059